Advertisement

Topics

Companies Related to "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients" [Most Relevant Company Matches] - Page: 4 RSS

17:18 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients" found in our extensive corporate database of over 50,000 company records.

Showing "Blood Samples Identify Biomarkers Haploidentical Graft Recipients" Companies 76–100 of 1,800+

Relevant

CaridianBCT

CaridianBCT is the leading global provider of innovative technologies and services specializing in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies. The company serves patients through its commitment “For Better Blood and Better Lives” by developing and commerci...


HemaSure Incorporated

HemaSure Inc. is a wholly-owned subsidiary of Sepracor Inc. ("Sepracor"). Sepracor transferred to the Hemasure its technology relating to the manufacture, use and sale of medical devices for the separation and purification of blood, blood products and blood components and its membrane filter design technologies.

Geneprot Inc.

GeneProt, Inc. is a life science company using the very latest developments in protein technologies to improve the quality and speed of the drug discovery and development process. GeneProt employs state-of-the-art technologies to separate, identify, characterize and synthesize proteins for bioassays. Through its high level of expertise in protein science and bioinformatics, GeneProt is facilitatin...


Pharmablood

PharmaBlood performs R&D of personalized medical treatment methods using as therapeutic agents autologous blood derivative compositions in cancer patients.PharmaBlood is a trademark of Telemedical Organization Inc used to identify the activity of the company in the field of research and development of blood derivatives as medical therapeuticals.Telemedical Organization Inc is an American company w...

Fenwal Inc.

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containe...

The Centre of Excellence for the Prevention of Organ Failure

The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) develops blood tests to diagnose, treat and manage heart, lung and kidney disease. The PROOF Centre is a cross-disciplinary engine of partners representing academia, health care, government, industry, patients and the public, to improve heart, lung and kidney health and reduce the ...

Gentra Systems, Inc.

Gentra Systems, Inc. is a privately held biotechnology corporation that was founded in 1988. Focused solely on nucleic acid purification, Gentra develops and markets manual and automated nucleic acid purification products that address the need for high quality nucleic acid, ease of use and increased throughput for clinical and clinical research laboratories.When Dr. Ruth Shuman founded Gentra, pur...

Rules-Based Medicine, Inc.

Rules-Based Medicine's biomarker testing service provides clinical researchers, physicians and healthcare providers with reproducible, quantitative, multiplexed data for hundreds of proteins to advance drug development and patient care. The Company's proprietary Multi Analyte Profiling (MAP) technology offers pre-clinical and clinical researchers broad, cost-effective protein analyses in multiple ...

Cleveland HeartLab Inc.

Cleveland HeartLab Inc. is a clinical laboratory and disease management company spun out of Cleveland Clinic in 2009. It offers a robust menu of propriety diagnostic tests for the assessment of cardiovascular disease risk that are based on high value molecular biomarkers. CHL operates a CLIA-certified and CAP-accredited clinical laboratory that provides ph...

Donor Dialogue

Donor Dialogue, a division of Dialogue Marketing, provides products and services to help blood centers be more efficient, productive and profitable. Donor Dialogue’s Customer Relationship Management (CRM) software, targeted marketing tools and data analysis services support blood center operations to drive blood donor recruitments. With its highly tra...

Hemobiotech

What is HemoBioTech, Inc.’s current product offering? HemoBioTech, Inc.’s product is HemoTech™, potentially the first viable human blood substitute addressing the broad blood use market. What is HemoBioTech, Inc.’s mission? Our mission is to commercialize HemoTech™ as potentially the first viable substitute for human blood addressing a blood market of over $25 billion. Our goal is to ...

Sanquin

Sanquin was established in 1998 through a merger between the Dutch blood banks and the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). The Foundation is responsible for blood supply on a not-for-profit basis and advances transfusion medicine as such that it fulfils the highest demands for quality, safety and efficiency. Sanquin delivers products and services, condu...

Singulex, Inc

Singulex pioneered technology that can quantitatively detect single molecules such as proteins and metabolites in complex biological samples. Our patented technology extends the dynamic range of any immunoassay by orders of magnitude, allowing drug developers to use biomarkers to measure drug efficacy, safety and disease progression. In addition, our technology is applicable to the diagnostics mar...

Cleveland Cord Blood Center

Following the delivery of a full-term newborn and collection of cord blood, a CCBC nurse collection coordinator at each hospital ensures that the cord blood is safely transported to the CCBC's 5,000 square-foot clinical facility in Cleveland, Ohio. At CCBC's clinical laboratory, the cord blood is assessed, typed and frozen in a liquid nitrogen cryopreservation system. UCB are listed on internation...

Probably Relevant

WaveSense

WaveSense is a line of products designed to improve the quality of diabetes care by using a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. The company also makes Zero-Click(TM), a diabetes data management system designed to simplify data download. Together t...

Fenwal, Inc.

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experience and commitment to transfusion medicine. The company offers the broadest range of products for the automated and manual collection of blood ...

SurGenTec LLC

SurGenTec is an ISO 13485 certified medical device manufacturer based out of Boca Raton, FL. The company develops innovative products focused on minimally invasive surgical solutions. SurGenTec was recently awarded the 2018 Spine Technology Award presented at NASS for their ALARA Access Needle. This new technology will be released in early December 2018. The ...

caprotec bioanalytics GmbH

caprotec bioanalytics GmbH is a Berlin-based biotech company focusing on the commercialization of its proprietary Capture Compound Mass Spectrometry (CCMS) technology. The core of the CCMS technology consists of small, tri-functional molecules called capture compounds(TM). They enable a targeted isolation of proteins directly from complex biological samples. After isolation the captured proteins a...

Nohla Therapeutics Inc.

Nohla’s goal is to transform the medical care options for patients with our expanded cord blood product. The proprietary expansion platform multiplies the number of stem cells found in cord blood donations up to 500 times. This landmark advance made cord blood a viable alternative to adult bone marrow in the transplant setting.

NuGEN Technologies Inc.

NuGEN Technologies is the leader in providing solutions which make biological samples accessible for genomic analysis, enabling scientists to capture the truest biology achievable, independent of the quantity or quality of the samples. The company has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagno...

Trans Ova Genetics

Trans Ova Genetics grew out a desire to provide superior reproductive technology to seedstock producers in the Midwest. In 1980 Dr. David Faber and Dr. Daryl Funk had the foresight to provide "on farm" embryo transfer services in conjunction with their large animal veterinary practice. In a very short period of time, the demand for embryo transfer services grew significantly, and a limited "in cli...

Immucor, Inc.

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our w...

ReviveMed Inc.

ReviveMed’s founders at MIT developed a pioneering AI platform to address the challenges of accessing metabolomics data. ReviveMed’s platform consists of a proprietary AI algorithm which utilizes a comprehensive knowledge-based graphical database of metabolites to understand their interactions with proteins and their associations with diseases. T...

DNA Genotek, Inc.

DNA Genotek develops products that optimize ease of collection and provide superior samples and proven performance for those requiring high-quality biological samples for nucleic acid testing. High-quality samples that are easily collected from target populations enable our customers to focus on translating their analysis and testing into significant worldwide advancements in health and science. D...

Singulex Inc.

Singulex develops and commercializes innovative technology solutions that enable disease understanding and management for life science researchers and clinicians. Utilizing proprietary quantitative single molecule detection technology, Singulex develops customized biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers in a variety of biological samples...


More From BioPortfolio on "Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks